Home Tags Shire
Healthcare deals hit an all-time record in 2018. See the 7 biggest tie-ups that could change how we buy drugs and treat diseases.
A record $421 billion in healthcare deals have been announced this year. A global pharma deal and a US insurance merger are among the largest.
Takeda is closing in on buying Adderall maker Shire for $64 billion in pharma’s biggest deal of the year
Takeda has reached a deal to buy Adderall drugmaker Shire for $64 billion. The deal comes after a handful of rejections from Shire and a short-lived potential for a bidding war between Takeda and Botox-maker Allergan.
Shire has already turned down three offers already from the Japanese pharmaceutical company Takeda, including one worth $60 billion.
Shire rejected a $60 billion bid from the Japanese drugmaker Takeda, while Allergan briefly considered getting into the fray on Thursday.
Shire CEO Flemming Ornskov told Business Insider that there were certain ways he expected the tech industry to enter the pharma space.
Business Insider asked Shire CEO Flemming Ornskov for his best career advice.
Shire CEO Flemming Ornskov thinks routines are very important and tries to swim every day.
Shire CEO Flemming Ornskov said there were a few reasons there aren't many deals right now — but that that won't always be the case.
Shire CEO Flemming Ornskov is concerned about whether the legislation would make changes to how people with existing illnesses get coverage.
Shire's $32 billion takeover of Baxalta makes it a leader in the treatment of rare diseases.